Show Notes
In this episode, we discuss the optimism among Connecticut cannabis dispensaries following news that the federal government may reclassify cannabis from a Schedule I to a Schedule III drug. This potential change could provide significant benefits, such as improved access to financial services, reduced tax burdens, and more robust market growth. Dispensaries are hopeful that reclassification will address many of the challenges they currently face, making the industry more sustainable and accessible.
Tune in for more insights. Learn more here.
